There are 3 papers on MIR191 in aging research: 2 observational studies in people, 1 in cells.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 1 country
- Funders: Ministry of Science and ICT, South Korea and 2 more
- Humans2
- Cells1
Interventions
1Arachidonyl-2'-chloroethylamide
downin rat cells1
1 study
Arachidonyl-2'-chloroethylamide
downin rat cells1
Arachidonyl-2'-chloroethylamide decreases MIR191 in HU-induced senescent cells.
“Increased expression of miR-191-5p by HU was restored by CB1 agonist ACEA co-treatment.”
Cellsin HU-induced senescent cells
Cannabinoid receptor type 1 in the aging gut regulates the mucosal permeability via miR-191-5p
Frontiers in endocrinology
Latest
1 paper in 12 monthsEpigenomes
Upregulation of a MicroRNA Signature Involving miR-17-5p, miR-26b-5p, miR-106a-5p, and miR-146a-5p During Cervical Epithelial Transformation
Cross-sectional study of 72 peopleBiomarkers
Frontiers in Endocrinology
Cannabinoid receptor type 1 in the aging gut regulates the mucosal permeability via miR-191-5p
Experiments in rat cellsGut and microbiome